BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6303232)

  • 1. [Comparative study of the humoral markers associated with hepatitis B virus in hepatocellular carcinoma patients and in subjects with chronic hepatopathy].
    de Franchis R; Primignani M; Vecchi M; Zannier PM; Colombo M; Colucci G; Antoniozzi F; Tommasini M
    Ann Sclavo; 1982; 24(1):37-48. PubMed ID: 6303232
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B viral infection: part I. Clinical features.
    Dzik WH; Alter HJ
    Am Fam Physician; 1982 Aug; 26(2):119-26. PubMed ID: 6285684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-control study of hepatitis B virus infection in chronic liver disease and hepatocellular carcinoma.
    de Franchis R; Primignani M; Vecchi M; Antoniozzi F; Colombo M; Colucci G; Tommasini M
    Ric Clin Lab; 1984; 14(1):81-8. PubMed ID: 6328629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relation of hepatitis B virus to chronic hepatitis, cirrhosis and primary hepatocellar carcinoma--a study of 367 cases of liver biopsy with orcein staining].
    Tang YH
    Zhonghua Nei Ke Za Zhi; 1983 Jan; 22(1):17-20, 62-3. PubMed ID: 6188585
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.
    Kubo Y; Okuda K; Hashimoto M; Nagasaki Y; Ebata H
    Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatocellular carcinoma (CHC) in patients chronically infected with HBV].
    Zielińska W; Kiszkis H; Dybicki J; Zbrzeźniak G; Zółtowska A; Jankowski Z; Sliwińska I
    Przegl Epidemiol; 1991; 45(4):279-85. PubMed ID: 1668701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of HBsAg and anti-HBs in patients with primary liver cancer or hepatic metastases.
    Nastac E; Stoian M; Iosipenco M; Iordache C
    Virologie; 1985; 36(3):181-6. PubMed ID: 3000067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of markers correlated with the hepatitis B virus in patients with alcoholic hepatopathy].
    Stefanini GF; Tisselli N; Baraldini M; Boccia S; Gullini S; Pignatelli M; Miglio F
    G Clin Med; 1982 Oct; 63(10):688-98. PubMed ID: 7182194
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B virus DNA and human hepatocellular carcinoma.
    Brechot C; Wain-Hobson S; Pourcel C; Dejean A; Hadchouel M; Scotto J; Tiollais P
    Prog Clin Biol Res; 1983; 132D():495-504. PubMed ID: 6314366
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of cytotoxic chemotherapy on hepatitis B viral markers in patients with hepatocellular carcinoma.
    Zaman S; Melia W; Johnson P; White Y; Williams R
    Clin Oncol; 1984 Sep; 10(3):247-52. PubMed ID: 6090048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma.
    Karayiannis P; Fowler MJ; Lok AS; Greenfield C; Monjardino J; Thomas HC
    J Hepatol; 1985; 1(2):99-106. PubMed ID: 2997321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis B virus and primary hepatocellular carcinoma in Asia.
    Obata H; Nishioka K
    Southeast Asian J Trop Med Public Health; 1979 Dec; 10(4):621-6. PubMed ID: 94184
    [No Abstract]   [Full Text] [Related]  

  • 13. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
    Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
    Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current developments in hepatology].
    Banciu T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(4):289-300. PubMed ID: 2865791
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serological markers of hepatitis B virus in chronic hepatitis and cirrhosis].
    Rull S; Ruiz-Capellán R; Araiz J; Panizo A; Serrano M; Prieto-Valtueña J
    Rev Esp Enferm Apar Dig; 1985 Apr; 67(4):321-5. PubMed ID: 4001527
    [No Abstract]   [Full Text] [Related]  

  • 16. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis BeAg in chronic asymptomatic hepatitis B surface antigen carriers and in primary hepatocellular carcinoma patients.
    Tswana SA
    Cent Afr J Med; 1986 May; 32(5):113-6. PubMed ID: 3028639
    [No Abstract]   [Full Text] [Related]  

  • 18. [Morphological demonstration of hepatitis B virus surface antigen in liver cirrhosis, fibrosis and hepatocellular carcinoma (author's transl)].
    Chlumská A; Kautzner J
    Cas Lek Cesk; 1981 Jun; 120(23):689-92. PubMed ID: 6265089
    [No Abstract]   [Full Text] [Related]  

  • 19. HBV-DNA in sera of patients with HBsAg-positive primary liver cell carcinoma.
    Theilmann L; Gmelin K; Will H; Czygan P; Hasche G; Doerr HW; Kommerell B
    Z Gastroenterol; 1984 Apr; 22(4):182-7. PubMed ID: 6328781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis.
    Musca A; Cordova C; Barnaba V; Bonavita MS; Levrero M; Zaccari C; Balsano F
    Hepatogastroenterology; 1983 Feb; 30(1):3-5. PubMed ID: 6299916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.